Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 248.50
+1.70 (0.69%)
At close: Apr 16, 2026
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 3.16 billion as of April 16, 2026. Its market cap has decreased by -49.46% in one year.
Market Cap
3.16B
Enterprise Value
3.11B
Revenue
1.72B
Ranking
n/a
PE Ratio
42.53
Stock Price
248.50
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.16B, an increase of 2,812.35%. That is a compound annual growth rate of 17.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 3.14B | -32.02% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 4.43B |
| Albert David | 4.14B |
| ZIM Laboratories | 4.07B |
| Amanta Healthcare | 3.89B |
| Medico Remedies | 3.23B |
| Sat Kartar Life | 3.07B |
| Kerala Ayurveda | 3.07B |
| Trident Lifeline | 2.93B |